Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Published Online: 2022-01-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alan D Ramsay•Alexander Claviez•Alexander Fosså•Ana Fernández-Teijeiro•Andische Attarbaschi•Andrea Hraskova•Anne Uyttebroeck•Auke Beishuizen•Christine Mauz-Körholz•Dieter Körholz•Dietrich Stoevesandt•Dirk Hasenclever•Dirk Vordermark•Francoise Montravers•Georg Mann•Jean Pears•Jonas Karlén•Judith Landman-Parker•Jörg M Bartelt•Karin Dieckmann•Lars Kurch•Lisa L Hjalgrim•Michaela Cepelova•Regine Kluge•Richard A Anderson•Roland A Ammann•Sabah Boudjemaa•Stefan Gattenlöhner•Stephen Daw•Tanja Pelz•Thiery Leblanc•Thomas Georgi•Vladan Rajić•Walentyna Balwierz•William Hamish Wallace
